LYELL IMMUNOPHARMA INC (LYEL) Forecast, Price Target & Analyst Ratings

NASDAQ:LYEL • US55083R2031

Current stock price

24.01 USD
+0.31 (+1.31%)
At close:
24.01 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LYELL IMMUNOPHARMA INC (LYEL).

Forecast Snapshot

Consensus Price Target

Price Target
$40.12
+ 67.10% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.33
Revenue Estimate
4.488K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$40.12
Upside
+ 67.10%
From current price of $24.01 to mean target of $40.12, Based on 10 analyst forecasts
Low
$34.34
Median
$39.78
High
$47.25

Price Target Revisions

1 Month
2.16%
3 Months
2.16%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for LYEL. The average price target is 40.12 USD. This implies a price increase of 67.1% is expected in the next year compared to the current price of 24.01.
The average price target has been revised upward by 2.16% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LYEL Current Analyst RatingLYEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

LYEL Historical Analyst RatingsLYEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
LYEL was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about LYEL.
In the previous month the buy percentage consensus was at a similar level.
LYEL was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10NeedhamInitiate Buy
2026-03-09CitizensInitiate Market Outperform
2025-12-09HC Wainwright & Co.Upgrade Neutral -> Buy
2025-11-24HC Wainwright & Co.Maintains Neutral -> Neutral
2025-09-26LUCID CAPITAL MARKETSInitiate Buy
2025-06-24HC Wainwright & Co.Maintains Neutral -> Neutral
2025-04-16HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-03-13HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-11-12HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-10-30B of A SecuritiesDowngrade Buy -> Underperform
2024-10-28HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-08-19HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-06-27B of A SecuritiesMaintains Buy -> Buy
2024-06-27HC Wainwright & Co.Downgrade Buy -> Neutral
2024-05-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-29HC Wainwright & Co.Maintains Buy -> Buy
2023-11-09HC Wainwright & Co.Maintains Buy -> Buy
2023-08-28JP MorganDowngrade Overweight -> Neutral
2023-05-05HC Wainwright & Co.Reiterate Buy
2023-03-02HC Wainwright & Co.Maintains Buy
2023-01-24Morgan StanleyMaintains Equal-Weight
2022-11-14Morgan StanleyDowngrade Overweight -> Equal-Weight
2022-11-11Goldman SachsDowngrade Buy -> Neutral
2022-10-17HC Wainwright & Co.Initiate Buy
2022-05-24Goldman SachsMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.33
Revenue Estimate
4.488K
Revenue Q2Q
-35.89%
EPS Q2Q
34.25%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-30.49%
Revenue (3 Months)
N/A
EPS (1 Month)
-10.35%
EPS (3 Months)
-6.64%

Next Earnings Summary

LYEL is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -2.33 USD and the consensus revenue estimate is 4.49K USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
LYEL revenue by date.LYEL revenue by date.
130K
-99.85%		61K
-53.08%		36K
-40.98%		17.544K
-51.27%		1.546M
8,712.13%		53.691M
3,372.90%		103.02M
91.88%
EBITDA
YoY % growth
LYEL ebitda by date.LYEL ebitda by date.
-226.758M
-34.14%		-200.643M
11.52%		-190.09M
5.26%		-216.664M
-13.98%		-306.663M
-41.54%		-313.794M
-2.33%		N/A
EBIT
YoY % growth
LYEL ebit by date.LYEL ebit by date.
-247.008M
-32.05%		-220.274M
10.82%		-201.629M
8.46%		-207.483M
-2.90%		-242.836M
-17.04%		-267.948M
-10.34%		-286.518M
-6.93%
Operating Margin
LYEL operating margin by date.LYEL operating margin by date.
-190,006.15%-361,104.92%-560,080.56%-1,182,641.86%-15,707.39%-499.05%-278.12%
EPS
YoY % growth
LYEL eps by date.LYEL eps by date.
-15.60
-4.00%		-15.80
-1.28%		-16.06
-1.65%		-9.90
38.36%		-9.48
4.20%		-6.56
30.81%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-2.33
34.25%		-2.49
13.97%		-2.53
-18.76%		-2.51
66.51%		-2.16
7.41%		-2.17
12.82%		-1.92
24.19%		-1.45
42.09%		-1.69
21.82%		-1.50
30.68%		-1.26
34.52%		-1.48
-1.75%
Revenue
Q2Q % growth		4.488K
-35.89%		3.315K
-58.56%		3.315K
-77.90%		2.55K
-57.50%		N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-48.175M
10.67%		-54.422M
-42.99%		-56.371M
-100.53%		-57.696M
-15.92%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-54.933M
4.24%		-58.885M
-31.93%		-62.003M
-66.44%		-65.514M
-6.85%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LYEL Yearly Revenue VS EstimatesLYEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
LYEL Yearly EPS VS EstimatesLYEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.75%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1,032.92%
Revenue Next 5 Year
626.78%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-17.34%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LYELL IMMUNOPHARMA INC / LYEL Forecast FAQ

What is the average price target for LYELL IMMUNOPHARMA INC (LYEL) stock?

10 analysts have analysed LYEL and the average price target is 40.12 USD. This implies a price increase of 67.1% is expected in the next year compared to the current price of 24.01.

What is the next earnings date for LYEL stock?

LYELL IMMUNOPHARMA INC (LYEL) will report earnings on 2026-05-11.

Can you provide the consensus estimates for LYELL IMMUNOPHARMA INC next earnings?

The consensus EPS estimate for the next earnings of LYELL IMMUNOPHARMA INC (LYEL) is -2.33 USD and the consensus revenue estimate is 4.49K USD.

What is the expected long term growth rate for LYELL IMMUNOPHARMA INC (LYEL)?

The expected long term growth rate for LYELL IMMUNOPHARMA INC (LYEL) is 1032.92%.